Marcus Alexander Mall
Impact in
- Pulmonary and Respiratory Medicine top 0.05%
- Cystic Fibrosis Research Advances
- Neonatal Respiratory Health Research
- Tracheal and airway disorders
- Emergency Medical Services top 0.2%
Papers in
-
- Cystic Fibrosis Research Advances 254
- Neonatal Respiratory Health Research 137
- Tracheal and airway disorders 53
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 15
-
- Pediatric health and respiratory diseases 26
- Co-authors
- Karl Kunzelmann (33 shared papers)Richard C. Boucher (16 shared papers)Simon Y. Graeber (50 shared papers)Rainer F. Greger (16 shared papers)Mirjam Stahl (74 shared papers)Wanda K. O’Neal (6 shared papers)Dominik Hartl (9 shared papers)Mark Oliver Wielpütz (51 shared papers)
- Journals
- Journal of Cystic Fibrosis (47 papers)European Respiratory Journal (36 papers)American Journal of Respiratory and Critical Care Medicine (32 papers)Annals of the American Thoracic Society (10 papers)PLoS ONE (10 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Marcus Alexander Mall
388 papers receiving 20.2k citations
Marcus Alexander Mall's Hit Papers
Peers
Comparison fields: 5 of 172
- Pulmonary and Respiratory Medicine 12.6k
- Emergency Medical Services 714
- Infectious Diseases 1.9k
- Immunology 1.5k
- Molecular Biology 4.2k
Countries citing papers authored by Marcus Alexander Mall
This map shows the geographic impact of Marcus Alexander Mall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcus Alexander Mall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcus Alexander Mall more than expected).
Fields of papers citing papers by Marcus Alexander Mall
This network shows the impact of papers produced by Marcus Alexander Mall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcus Alexander Mall. The network helps show where Marcus Alexander Mall may publish in the future.
Co-authors
The 25 scholars most cited alongside Marcus Alexander Mall, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 415 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Elexacaftor–Tezacaftor–Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele Hit paper breakdown → | 2019 | 1595 |
| 2 | Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial Hit paper breakdown → | 2019 | 1064 |
| 3 | SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19 Hit paper breakdown → | 2020 | 985 |
| 4 | Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice Hit paper breakdown → | 2004 | 763 |
| 5 | VX-445–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles Hit paper breakdown → | 2018 | 573 |
| 6 | 2002 | 550 | |
| 7 | 2018 | 258 | |
| 8 | Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children Hit paper breakdown → | 2021 | 251 |
| 9 | Cross-reactive CD4 + T cells enhance SARS-CoV-2 immune responses upon infection and vaccination Hit paper breakdown → | 2021 | 230 |
| 10 | 2014 | 228 | |
| 11 | 2014 | 223 | |
| 12 | 2005 | 215 | |
| 13 | Triple Therapy for Cystic Fibrosis Phe508del –Gating and –Residual Function Genotypes Hit paper breakdown → | 2021 | 214 |
| 14 | A Phase 3 Open-Label Study of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 through 11 Years of Age with Cystic Fibrosis and at Least One F508del Allele Hit paper breakdown → | 2021 | 214 |
| 15 | 2012 | 190 | |
| 16 | 1998 | 189 | |
| 17 | 2021 | 183 | |
| 18 | 2020 | 181 | |
| 19 | 2019 | 179 | |
| 20 | 2015 | 177 |
About Marcus Alexander Mall
Marcus Alexander Mall is a scholar working on Pulmonary and Respiratory Medicine, Emergency Medical Services, Physiology, Molecular Biology and Immunology, having authored 415 papers that have together received 20.6k indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (254 papers), Neonatal Respiratory Health Research (137 papers), Tracheal and airway disorders (53 papers), Pediatric health and respiratory diseases (26 papers), Ion Transport and Channel Regulation (25 papers), Asthma and respiratory diseases (24 papers), Respiratory viral infections research (18 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (15 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (12.6k citations), Emergency Medical Services (714 citations), Infectious Diseases (1.9k citations), Immunology (1.5k citations) and Molecular Biology (4.2k citations). Marcus Alexander Mall has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Karl Kunzelmann, Richard C. Boucher, Simon Y. Graeber, Rainer F. Greger, Mirjam Stahl, Wanda K. O’Neal, Dominik Hartl, Mark Oliver Wielpütz, Jack R. Harkema and Barbara R. Grubb. Their work appears in journals such as Journal of Cystic Fibrosis, European Respiratory Journal, American Journal of Respiratory and Critical Care Medicine, Annals of the American Thoracic Society and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.